Menu
search
0

High-throughput Antibody Discovery with Cyto-Mine®: Identifying High-value Targets for Cancer Immunotherapy

case study icon

High-throughput Antibody Discovery with Cyto-Mine®: Identifying High-value Targets for Cancer Immunotherapy

case study icon
Cyto-Mine product image

Summary

Discover how Cyto-Mine® technology enables high-throughput, high-depth screening in antibody discovery workflows. This 2025 publication in mAbs highlights how our microfluidic technology rapidly identifies thousands of target hit antibodies, leading to the identification of therapeutic candidates.

Research highlights

  • Study Title: AbDrop-a scalable microfluidics-enabled platform for rapid discovery and functional analysis of plasma cell-derived antibodies
  • Authors: Meng Yu, Liang Wang, Yan Yang, Su Liang, Yiyang Ge, Huanlei Xi, Shipin Lin, Ying Chen, Wei Liu, Weihua Wang, Changchun Zha & Haisong Lu
  • Published In: mAbs Journal, 2025
  • DOI: 10.1080/19420862.2025.2597610

Key findings

  • High Throughput: By using Cyto-Mine® technology, researchers screened 1-2 million plasma cells per run, enabling recovery of hundreds to thousands of target antibody hits.
  • High-depth Screening: : Leveraging Cyto-Mine®’s high-throughput, Biointron was able to screen near-complete coverage of the antigen-specific repertoire of plasma cells recovered from spleen, bone marrow, and lymph nodes.
  • High-Speed Discovery: By speeding up the antibody discovery process using Cyto-Mine®, Biointron was able to go from single, plasma cells to recovered, unique antibody sequence within a week.

Additional Highlights

  • Biointron achieved 90.3% paired heavy and light chain sequence recovery, generating sequences for 2899/3209 dispense droplets from Cyto-Mine®.
  • 52/52 re-expressed antibodies (a selected subset) showed reconfirmed binding to the target.
Read the full study

Why Cyto-Mine®?

Learn how Cyto-Mine® supports leading-edge research in antibody discovery, enabling scientists to isolate the best candidates with precision and efficiency. Visit our Cyto-Mine® product page to explore the technology that is empowering today’s breakthroughs in biotherapeutics.

The Next Generation: Cyto-Mine® Chroma

Automate. Accelerate. Analyze millions of cells in a single day.

Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.

Cyto-Mine® Chroma
Contact sales